TARS
Tarsus Pharmaceuticals Inc.
$55.63
+$0.63(+1.15%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$2.32B
Volume
721.72K
52W Range
$31.36 - $59.76
Target Price
$74.57
EPS Estimates Overview
| Current Quarter | $-0.38 | Next Quarter | $-0.08 |
| Current Year | $-1.4 | Next Year | $0.59 |
| QoQ Growth | +78.9% | YoY Growth | +142.1% |
| 3Y EPS CAGR | -66.1% | Target Price | $74.57 |
| Consensus | Buy | Upside | +34.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TARS | $55.63 | +1.1% | 721.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tarsus Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW